Send feedback

FTCD p.Ala483Val

c.1448C>T · rs145609043 · VCV595818

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.6583 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0513%, eas)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.6583likely pathogenic
REVEL0.47indeterminate
SaProtLLR -12.85damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 11GERP 1.2, phastCons 1
Regional constrainto/e 1.12unconstrained · MANE · 19 kb · p 0.00063 · regional, not allelic
Overall
CADD29.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0513% East Asian · 23/44,866 alleles
Filtering AF 0.035% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0296%
Overall 0.0212% 342/1,612,432 alleles · ultra-rare exomes 312/1,460,114 · genomes 30/152,318 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.524% 191
East Asiangrpmax 0.0513% 1,951
Remaining individualsnot grpmax-eligible 0.0496% 2,015
Middle Eastern 0.033% 3,030
European (non-Finnish) 0.01% 9,991
Admixed American 0.00833% 12,006
South Asian 0.00769% 13,008
African / African-American 0.00133% 75,010

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FTCD
Protein
p.Ala483Val
Coding
c.1448C>T
MANE Select
NM_206965
dbSNP
rs145609043
Type
single nucleotide variant
Location
chr21:46137330 (GRCh38)
Gene constraint
LOEUF 1.61 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 95.30
Residue 483
the 'cyclodeaminase/cyclohydrolase' region
Full FTCD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ftcd-p-ala483val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown